• Contact Us
  • Glossary
  • Useful Websites
  • Download Library
  • Alert Service
  • About Vernalis
  • R & Centre
  • Business Development
  • Investor Centre
  • News Centre
  •  
  • Home

News Centre

Home / News Centre / Latest Releases / 2006
PrintEmailBookmark
  • Latest Releases
  • Regulatory Announcements
  • Vernalis Group Archive
  • British Biotech Archive
  • RiboTargets Archive
  • Media Contacts

Latest Releases

  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
20/12/2006 Vernalis Plc Strengthens Commercial Expertise by new Appointment to the Board - Ian Clark from Genentech
11/12/2006 Vernalis Plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type II Diabetes
21/11/2006 Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006
20/11/2006 Vernalis Plc Announces Progress on its Oncology Hsp90 Programme
02/11/2006 Vernalis to Present at Cowen and Company 7th Annual Global Health Care Conference
20/09/2006 Vernalis plc Announces FDA Acceptance for Filing of FrovaŽ for Short-Term Prevention of Menstrual Migraine
20/09/2006 Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006
12/09/2006 Vernalis plc: Interim Results for the Six Months Ended 30 June 2006
23/08/2006 Vernalis: Notice of Interim Financial Results
03/08/2006 Vernalis Starts Phase IIa Trial of V3381 in Diabetic Neuropathic Pain
Page 1  2    >>
  • Privacy
  • Legal
  • Site Map